| Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial RS Kahn, WW Fleischhacker, H Boter, M Davidson, Y Vergouwe, ... The lancet 371 (9618), 1085-1097, 2008 | 1412 | 2008 |
| How mental health care should change as a consequence of the COVID-19 pandemic C Moreno, T Wykes, S Galderisi, M Nordentoft, N Crossley, N Jones, ... The lancet psychiatry 7 (9), 813-824, 2020 | 1283 | 2020 |
| Toward a new definition of mental health S Galderisi, A Heinz, M Kastrup, J Beezhold, N Sartorius World psychiatry 14 (2), 231, 2015 | 916 | 2015 |
| Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST) M Davidson, S Galderisi, M Weiser, N Werbeloff, WW Fleischhacker, ... American Journal of Psychiatry 166 (6), 675-682, 2009 | 430 | 2009 |
| The influence of illness‐related variables, personal resources and context‐related factors on real‐life functioning of people with schizophrenia S Galderisi, A Rossi, P Rocca, A Bertolino, A Mucci, P Bucci, P Rucci, ... World Psychiatry 13 (3), 275-287, 2014 | 397 | 2014 |
| The current conceptualization of negative symptoms in schizophrenia SR Marder, S Galderisi World Psychiatry 16 (1), 14-24, 2017 | 392 | 2017 |
| Negative symptoms of schizophrenia: new developments and unanswered research questions S Galderisi, A Mucci, RW Buchanan, C Arango The Lancet Psychiatry 5 (8), 664-677, 2018 | 378 | 2018 |
| The status of spectral EEG abnormality as a diagnostic test for schizophrenia NN Boutros, C Arfken, S Galderisi, J Warrick, G Pratt, W Iacono Schizophrenia research 99 (1-3), 225-237, 2008 | 346 | 2008 |
| EEG microstate duration and syntax in acute, medication-naive, first-episode schizophrenia: a multi-center study D Lehmann, PL Faber, S Galderisi, WM Herrmann, T Kinoshita, ... Psychiatry Research: Neuroimaging 138 (2), 141-156, 2005 | 334 | 2005 |
| Deconstructing vulnerability for psychosis: meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk P Fusar-Poli, M Tantardini, S De Simone, V Ramella-Cravaro, D Oliver, ... European Psychiatry 40, 65-75, 2017 | 327 | 2017 |
| Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study M Maj, L D'Elia, P Satz, R Janssen, M Zaudig, C Uchiyama, F Starace, ... Archives of clinical Neuropsychology 8 (2), 123-135, 1993 | 322 | 1993 |
| The cortical generators of P3a and P3b: a LORETA study U Volpe, A Mucci, P Bucci, E Merlotti, S Galderisi, M Maj Brain research bulletin 73 (4-6), 220-230, 2007 | 299 | 2007 |
| Oxytocin receptor polymorphisms and adult attachment style in patients with depression B Costa, S Pini, P Gabelloni, M Abelli, L Lari, A Cardini, M Muti, C Gesi, ... Psychoneuroendocrinology 34 (10), 1506-1514, 2009 | 288 | 2009 |
| Prevention of psychosis: advances in detection, prognosis, and intervention P Fusar-Poli, GS de Pablo, CU Correll, A Meyer-Lindenberg, MJ Millan, ... JAMA psychiatry 77 (7), 755-765, 2020 | 284 | 2020 |
| Sources of cortical rhythms in adults during physiological aging: a multicentric EEG study C Babiloni, G Binetti, A Cassarino, G Dal Forno, C Del Percio, F Ferreri, ... Human brain mapping 27 (2), 162-172, 2006 | 283 | 2006 |
| Deficit schizophrenia: an update B Kirkpatrick, S Galderisi World Psychiatry 7 (3), 143, 2008 | 249 | 2008 |
| Schizophrenia—time to commit to policy change WW Fleischhacker, C Arango, P Arteel, TRE Barnes, W Carpenter, ... Schizophrenia bulletin 40 (Suppl_3), S165-S194, 2014 | 230 | 2014 |
| Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis S Galderisi, P Rucci, B Kirkpatrick, A Mucci, D Gibertoni, P Rocca, A Rossi, ... JAMA psychiatry 75 (4), 396-404, 2018 | 197 | 2018 |
| Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome S Galderisi, P Bucci, A Mucci, B Kirkpatrick, S Pini, A Rossi, A Vita, M Maj Schizophrenia research 147 (1), 157-162, 2013 | 194 | 2013 |
| Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial S Galderisi, A Mucci, I Bitter, J Libiger, P Bucci, WW Fleischhacker, ... European Neuropsychopharmacology 23 (3), 196-204, 2013 | 192 | 2013 |
